Charles River Laboratories (CRL) — insider trading
Health Care
Charles River Laboratories (CRL) has 29 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 29 (latest 2026-06-29).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-29 | FOSTER JAMES C | Director | Open-market sale | 75,000 | $225.00 | $16.88M | Form 4 |
| 2026-06-05 | Parisotto Shannon M | Officer (CEVP, Disc & Safety Assessment) | Bona fide gift | 1,529 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Parisotto Shannon M | Officer (CEVP, Disc & Safety Assessment) | Bona fide gift | 1,529 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Girshick Birgit | Officer (Chief Executive Officer) | Bona fide gift | 3,386 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Girshick Birgit | Officer (Chief Executive Officer) | Bona fide gift | 3,386 | $0.00 | $0 | Form 4 |
| 2026-06-05 | FOSTER JAMES C | Director | Bona fide gift | 10,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | FOSTER JAMES C | Director | Bona fide gift | 10,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | FOSTER JAMES C | Director | Bona fide gift | 20,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | FOSTER JAMES C | Director | Bona fide gift | 20,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | FOSTER JAMES C | Director | Bona fide gift | 153,361 | $0.00 | $0 | Form 4 |
| 2026-06-05 | FOSTER JAMES C | Director | Bona fide gift | 153,361 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Barg Steven | Director | Grant / award / vesting | 422 | $174.79 | $73.8K | Form 4 |
| 2026-05-31 | Creamer Victoria L | Officer (EVP & Chief People Officer) | Shares withheld for taxes / exercise cost | 194 | $180.71 | $35.1K | Form 4 |
| 2026-05-31 | Girshick Birgit | Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 378 | $180.71 | $68.3K | Form 4 |
| 2026-05-31 | Knell Michael Gunnar | Officer (SVP, Finance and CAO) | Shares withheld for taxes / exercise cost | 48 | $180.71 | $8.7K | Form 4 |
| 2026-05-31 | LaPlume Joseph W | Officer (EVP, Corp Strategy & Develop) | Shares withheld for taxes / exercise cost | 235 | $180.71 | $42.5K | Form 4 |
| 2026-05-31 | Mintz Mark | Officer (EVP, Chief Information Officer) | Shares withheld for taxes / exercise cost | 64 | $180.71 | $11.6K | Form 4 |
| 2026-05-30 | Creamer Victoria L | Officer (EVP & Chief People Officer) | Shares withheld for taxes / exercise cost | 616 | $180.71 | $111.3K | Form 4 |
| 2026-05-30 | FOSTER JAMES C | Director | Shares withheld for taxes / exercise cost | 1,596 | $180.71 | $288.4K | Form 4 |
| 2026-05-30 | Girshick Birgit | Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 1,204 | $180.71 | $217.6K | Form 4 |
| 2026-05-30 | Knell Michael Gunnar | Officer (SVP, Finance and CAO) | Shares withheld for taxes / exercise cost | 152 | $180.71 | $27.5K | Form 4 |
| 2026-05-30 | LaPlume Joseph W | Officer (EVP, Corp Strategy & Develop) | Shares withheld for taxes / exercise cost | 744 | $180.71 | $134.4K | Form 4 |
| 2026-05-30 | Mintz Mark | Officer (EVP, Chief Information Officer) | Shares withheld for taxes / exercise cost | 305 | $180.71 | $55.1K | Form 4 |
| 2026-05-29 | Creamer Victoria L | Officer (EVP & Chief People Officer) | Grant / award / vesting | 5,135 | $180.71 | $927.9K | Form 4 |
| 2026-05-29 | Girshick Birgit | Officer (Chief Executive Officer) | Grant / award / vesting | 9,961 | $180.71 | $1.80M | Form 4 |
| 2026-05-29 | Knell Michael Gunnar | Officer (SVP, Finance and CAO) | Grant / award / vesting | 1,837 | $180.71 | $332.0K | Form 4 |
| 2026-05-29 | LaPlume Joseph W | Officer (EVP, Corp Strategy & Develop) | Grant / award / vesting | 5,257 | $180.71 | $950.0K | Form 4 |
| 2026-05-29 | Mintz Mark | Officer (EVP, Chief Information Officer) | Grant / award / vesting | 2,534 | $180.71 | $457.9K | Form 4 |
| 2026-05-29 | Coleman Glenn | Officer (EVP & Chief Financial Officer) | Grant / award / vesting | 6,640 | $180.71 | $1.20M | Form 4 |
Ask the chat about CRL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Charles River Laboratories (CRL).
Last updated 2026-06-29 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.